Gouin, Francois
Stoeckle, Eberhard
Honoré, Charles
Ropars, Mickael
Jafari, Mehrdad
Mattei, Jean Camille
Rochwerger, Alexandre
Carrere, Sébastien
Waast, Denis
Ferron, Gwenaël
Machiavello, Jean-Christophe
Anract, Philippe
Marchal, Frédéric
Sirveaux, François
Marco, Oren
Guiramand, Jérôme
Paquette, Brice
Di Marco, Antonio
Causeret, Sylvain
Guilloit, Jean-Marc
Soibinet, Pauline
Tzanis, Dimitri
Gimbergues, Pierre
Fiorenza, Fabrice
Dujardin, Franck
Le Nail, Louis R.
Ruzic, Jean-Christophe
Chemin-Airiau, Claire
Morelle, Magali
Meeus, Pierre
Karanian, Marie
Le Loarer, François
Vaz, Gualter
Blay, Jean-Yves
,
Article History
Received: 15 April 2022
Accepted: 9 September 2022
First Online: 3 October 2022
Declarations
:
: NETSARC () is a network of 26 reference sarcoma centers with specialized multidisciplinary tumor boards (MDTB) funded by the French NCI (INCa). Since 2010, presentation to MDTB and second pathological review are mandatory for sarcoma patients. This research was conducted in accordance with relevant guidelines and local regulation. Namely, the study received approval from the national Advisory Committee on Information Processing in Health Research (<i>Comité consultatif sur le traitement de l’information en matière de recherche dans le domaine de la santé (CCTIRS)</i> n°10.403, on September 16, 2010, in accordance with the law n°94-548 (1<sup>st</sup> July 1994) and from the French data protection authority (<i>Commission Nationale Informatique et Liberté, CNIL),</i> n° 910390, on July 15, 2013, in accordance with the provisions of French Law of 6 January 1978 "Loi Informatique et Libertés", as amended. In accordance with the local regulation, the dataset of the study was pseudonymized. Anonymised data sets are available upon reasonable request from the data protection officer of the Léon Bérard cancer center at .
: Not applicable.
: The authors declare no conflict of interest.